Amphastar falls on CRL for intranasal naloxone

Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) dropped $4.20 (23%) to $14.20 on Tuesday after it said it received a complete

Read the full 180 word article

User Sign In